Enrico Zanardo

Vice President
Enrico Zanardo
Denver

Education

Ph.D. and M.Phil., economics, Columbia University; M.S., applied mathematics, and B.A., mathematics, University of Padua, Italy

Summary of Experience

Dr. Enrico Zanardo is a vice president at Analysis Group specializing in health economics and outcomes research (HEOR), with deep expertise in real-world evidence (RWE) generation and market access strategy. He develops economic and statistical models to evaluate health outcomes, treatment patterns, and the clinical and economic burden of disease across a broad range of therapeutic areas, including psychiatry, dermatology, hematology, oncology, and neurology. Dr. Zanardo has extensive experience working with real-world data sources – including medical and pharmacy claims, electronic medical records, patient surveys, and targeted literature reviews – to help life sciences clients quantify unmet need, assess product value, and inform evidence strategy. He has led engagements evaluating health care resource utilization (HRU) and costs, formulary access challenges, and comparative effectiveness of treatments in real-world practice. He also applies advanced analytic techniques, including predictive modeling and machine learning, to generate insights that support both regulatory and commercial decision making. Across his portfolio, Dr. Zanardo partners closely with pharmaceutical and biotech clients to design rigorous studies that address strategic objectives, from understanding patient journeys to assessing the impact of policy or formulary design on patient outcomes. His work bridges academic research standards with real-world constraints to deliver clear, actionable evidence for diverse stakeholders.

Enrico Zanardo
Practices